Replies to post #2098 on Acadia Pharmaceuticals Inc. (ACAD)

[masterbug1]

You got that right. They going to keep it low until news. That's why they down grade so they can flush out panic investors and also institutions can get it cheaper. Just look at the chart it all written on it. Also we may get a surprise tomorrow's PR
GLTA, I'm not selling until I see above 60s and mark this post, it will

[EFHutton7]

If longs are lucky! They wait too long and they will be bidding it at today's closing price when it hits mid teens in a month.

[Tanis2476]

Buyout won't come until they get additional indications. They won't take a buyout now, wait until it's $60 a share on its own, but that won't come from this one indication. This patient population is too small to be a blockbuster.

See Avanir, once phase 2 data came out on Agitation in Alzheimer's, they got bought. If ACAD gets great data on Psychosis, this goes through the roof. Too bad the product is classified as an anti psychotic. Will hurt sales in geriatrics.

[2014shelby]

How much time do you think the Baker Bros are gonna allow for a BO? The acquiring firm will most likely bring in their own top mgt. and in this case it appears they need it anyway.

Also, It's interesting that mgt didn't establish, or at least make public, a price for the drug. What's your take on that and the insider sales a few weeks ago?